GSK Investigational Site

Green Bay, Wisconsin 54311

0 studies enrolling now · 6 studies all time

What they study most

Acute Coronary Syndrome, BRCA1 Gene Mutation, BRCA2 Gene Mutation, Carcinoma of Breast, HIV Infection, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Lung Cancer, Small Cell, Neoplasms, Breast, Ovarian Neoplasms, Small Cell Lung Cancer

Studies at this site

• A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients — Stopped early
• The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial — Completed
• The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) — Completed
• Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer — Completed
• Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure — Completed
• A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy — Completed